1. Home
  2. SPCE vs MDWD Comparison

SPCE vs MDWD Comparison

Compare SPCE & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virgin Galactic Holdings Inc.

SPCE

Virgin Galactic Holdings Inc.

N/A

Current Price

$2.93

Market Cap

331.6M

ML Signal

N/A

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$13.16

Market Cap

181.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCE
MDWD
Founded
2017
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Transportation Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
331.6M
181.1M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
SPCE
MDWD
Price
$2.93
$13.16
Analyst Decision
Hold
Strong Buy
Analyst Count
5
1
Target Price
$3.06
$36.00
AVG Volume (30 Days)
6.6M
101.8K
Earning Date
05-14-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
60.84
N/A
EPS
N/A
N/A
Revenue
$1,544,000.00
N/A
Revenue This Year
$2,270.73
$48.92
Revenue Next Year
$880.03
$35.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.13
$12.52
52 Week High
$8.90
$20.03

Technical Indicators

Market Signals
Indicator
SPCE
MDWD
Relative Strength Index (RSI) 47.24 54.53
Support Level $2.84 $12.52
Resistance Level $3.39 $15.08
Average True Range (ATR) 0.13 0.48
MACD -0.01 0.14
Stochastic Oscillator 20.90 78.39

Price Performance

Historical Comparison
SPCE
MDWD

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: